GLP-1 gene delivery for the treatment of type 2 diabetes (Q40650831)

22 September 2017

title

GLP-1 gene delivery for the treatment of type 2 diabetes (English)

1 reference

22 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00036-4

29 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00036-4

29 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00036-4

29 December 2023

author name string

Seungjoon Oh

1

1 reference

22 September 2017

Minhyung Lee

2

1 reference

22 September 2017

Kyung Soo Ko

3

1 reference

22 September 2017

Suna Choi

4

1 reference

22 September 2017

Sung Wan Kim

5

1 reference

22 September 2017

language of work or name

1 reference

1 April 2003

1 reference

full work available at URL

22 September 2017

http://www.cell.com/article/S1525001603000364/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727110

https://api.elsevier.com/content/article/PII:S1525001603000364?httpAccept=text/xml

29 December 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S1525-0016(03)00036-4

https://api.elsevier.com/content/article/PII:S1525001603000364?httpAccept=text/plain

29 December 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S1525-0016(03)00036-4

29 December 2023

1 reference

22 September 2017

volume

7

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

478-483

1 reference

Glucagonlike peptide 1: a newly discovered gastrointestinal hormone

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Glucose-dependent action of glucagon-like peptide-1(7-37) in vivo during short- or long-term administration

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

The effect of glucose and glucagon-like peptide-1 stimulation on insulin release in the perfused pancreas in a non-insulin-dependent diabetes mellitus animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Design and gene delivery activity of modified polyethylenimines.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Poly(ethylenimine) and its role in gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Minireview: the glucagon-like peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900036-4

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference